Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

JAK inhibitors show promise for treating alopecia areata, but long-term safety and emotional support are important.

Tofacitinib effectively improves lichen planus pigmentosus symptoms.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Tofacitinib helped a 21-year-old regrow hair after alopecia totalis.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Tranexamic acid and oral retinoids may effectively treat lichen plan pigmentosus.

Baricitinib is an effective treatment for severe alopecia areata.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.